Comparison of HBV reactivation between patients with high HBV-DNA and low HBV-DNA loads undergoing PD-1 inhibitor and concurrent antiviral prophylaxis.
Min-Ke HeChuan PengYang ZhaoRun-Bin LiangZhi-Cheng LaiAnna KanQi-Jiong LiWei WeiYao-Jun ZhangMin-Shan ChenRong-Ping GuoMing ShiPublished in: Cancer immunology, immunotherapy : CII (2021)
With concurrent antiviral prophylaxis, HBV-DNA load higher than 500 IU/ml should not be a contraindication for PD-1 inhibitor.